Not applicableStudy completedNCT06463639What this trial is testingFLT3 Clonal Evolution in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Taiwan University Hospital 1,213
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05731219What this trial is testingUTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03160079What this trial is testingBlinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow LymphoblastsWho this might be right forB-Cell Acute Lymphoblastic Leukemia, Adult University of California, San Diego 16
Testing effectiveness (Phase 2)Ended earlyNCT04240002What this trial is testingGilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD) Astellas Pharma Global Development, Inc. 9
Early research (Phase 1)Study completedNCT01830777What this trial is testingBrentuximab Vedotin + Re-induction Chemotherapy for AMLWho this might be right forAcute Myelogenous Leukemia Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT02074657What this trial is testing"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute LeukemiaWho this might be right forRelapsed/Refractory Paediatric Acute Leukaemia Hospital Universitario La Paz 13
Testing effectiveness (Phase 2)Study completedNCT04323657What this trial is testingTC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more TCR2 Therapeutics 6
Very early researchLooking for participantsNCT04227015What this trial is testingCTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological MalignancyWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma He Huang 72
Early research (Phase 1)UnknownNCT05740917What this trial is testingTo Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDSWho this might be right forAMLMDS Xuanzhu Biopharmaceutical Co., Ltd. 82
Testing effectiveness (Phase 2)UnknownNCT05951855What this trial is testingStudy of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) PatientsWho this might be right forAcute Myeloid Leukemia (Relapsed/Refractory) The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515What this trial is testingProvision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationWho this might be right forAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more St. Jude Children's Research Hospital 170
Not applicableStudy completedNCT05456048What this trial is testingInfluence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AMLWho this might be right forRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaGene Abnormality+1 more Nanfang Hospital, Southern Medical University 231
Testing effectiveness (Phase 2)Ended earlyNCT02152956What this trial is testingFlotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)Who this might be right forAML MacroGenics 244
Not applicableStudy completedNCT02783651What this trial is testingPatients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the USWho this might be right forRelapsed/Refractory Acute Lymphoblastic Leukemia Amgen 212
Large-scale testing (Phase 3)Study completedNCT00002456What this trial is testingGraft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT07668557What this trial is testingAnti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) iCell Gene Therapeutics 18
Early research (Phase 1)Study completedNCT05548088What this trial is testingLILRB4 STAR-T Cells in the Treatment of R/R AML/CMMLWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia and Chronic Granulocytic-Mononocytic Leukemia Peking University People's Hospital 11
Testing effectiveness (Phase 2)Ended earlyNCT04639024What this trial is testingADCT-301 in Patients With R/R AML, MDS, or MDS/MPNWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Myeloproliferative Neoplasm (MDS/MPN) Gwynn Long, M.D. 3
Testing effectiveness (Phase 2)UnknownNCT04353479What this trial is testingCombined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Shanghai Jiao Tong University School of Medicine 29